publication date: Jul. 20, 2018

Funding Opportunities

DOD Breast Cancer Research Program Breakthrough Awards

FY18 BCRP Program Announcements and General Application Instructions for the following award mechanisms are posted on

Applications submitted to the FY18 BCRP must address one or more of the following overarching challenges:

Prevent breast cancer (primary prevention)

Identify determinants of breast cancer initiation, risk, or susceptibility

Distinguish deadly from non-deadly breast cancers

Conquer the problems of overdiagnosis and overtreatment

Identify what drives breast cancer growth; determine how to stop it

Identify why some breast cancers become metastatic

Determine why/how breast cancer cells lie dormant for years and then re-emerge; determine how to prevent lethal recurrence

Revolutionize treatment regimens by replacing them with ones that are more effective, less toxic, and impact survival

Eliminate the mortality associated with metastatic breast cancer

Breakthrough Award Level 1 & 2

Letter of Intent due Nov 1, 2018

Investigators at all academic levels (or equivalent) are eligible to be names as Principal Investigator.

Applications from senior postdoctoral fellows who do not meet the eligibility requirements of the Breakthrough Fellowship Award are encouraged underfunding Level 1 and 2.

Each investigator may be named on only one Funding Level 1 application and Funding Level 2 application as a PI or Initiating PI.

Supports promising research that has the potential to lead to or make breakthroughs in breast cancer.

Potential impact of the research may be near-term or long-term, but it must be significant and go beyond an incremental advancement.

Partnering PI Option allows two PIs, termed Initiating and Partnering PIs, to collaborate on a single application.

Continue reading DOD Breast Cancer Research Program Breakthrough Awards

To access this members-only content, please log in.
Institutional subscribers, please log in with your IP.
If you're not a subscriber why not join today?
To gain access to the members only content click here to subscribe.
You will be given immediate access to premium content on the site.
Click here to join.

Copyright (c) 2020 The Cancer Letter Inc.